Sterile compounding pharmacies, whether small 503A hospital facilities or large 503B GMP-compliantoutsourcing sites, face increasing pressure to meet evolving quality standards while protecting patients from
A lot has happened in the world of sterile, compounded medicine in the past decade – from the creation of sections 503A and 503B in
Our Endosafe(R) cartridge brochure offers in-depth insights into advanced endotoxin testing techniques, providing streamlined, rapid, and precise solutions that are not typically found in traditional
On August 1, 2025, the United States Pharmacopeia (USP) released Chapters <73> and <1071>, simplifying the adoption of ATP-bioluminescence-based Rapid Microbiological Methods (RMMs) like Celsis® for
In the realm of pharmaceutical compounding, ensuring the sterility and safety of preparations is paramount. Charles River offers a comprehensive suite of microbial solutions designed
With so many identification methods and service providers available, selecting the right one for your testing needs can be daunting. Let us simplify your decision-making
With Endosafe cartridge technology, any user can generate rapid, automated BET results in about 15 minutes, minimizing manual effort while aligning with regulatory standards and
The new draft of USP <73> is reshaping sterility testing for short-life products. To remain competitive and compliant, companies must adopt quicker, more efficient methods.
The new draft of USP <73> is reshaping sterility testing for short-life products. To stay competitive, companies must adapt quickly. Join our expert-led webinar “Understanding
The Role of Water Negative Controls in BET Water Negative Controls (WNCs) help verify BET accuracy by ensuring endotoxin results stem from the sample, not